Remove Manufacturing Remove Pharmaceutical research Remove Prescription
article thumbnail

And so pharma profiteers again

World of DTC Marketing

Best of all are patients in the US, where prices are highest, and with chronic conditions requiring repeat prescriptions. The argument is that this is the only way to cover research and development (R&D) cost for new drugs. The best prospects are drugs targeted at patients who are high-value and who will use the drugs long term.

Pharma 191
article thumbnail

Entry-Level Pharma Sales: It's More Than Just a Job Search (Here's Why)

Contrarian Sales Techniques

prescription drugs, medical devices), or specific companies. Utilize job boards: Explore dedicated job boards within the pharmaceutical industry, such as Pharmajobs, Medzilla, and BioSpace, alongside general job boards like LinkedIn and Indeed. This could include therapeutic areas (e.g., oncology, cardiology), product types (e.g.,

Sales 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Beating the Big C

Pharmaceutical Technology

.” While Pfizer is currently testing 18 medicines targeted against pancreatic, breast and lung cancers, figures released by the Pharmaceutical Research and Manufacturers of America [PhRMA] in April 2008 reveal that research companies are currently testing a record-breaking 750 experimental cancer drugs in America alone.

article thumbnail

PhRMA is going to have to write some big checks

World of DTC Marketing

SUMMARY: President Biden wants to lower prescription drug costs. Even though prescription drug costs are only $.11 The Pharmaceutical Research and Manufacturers of America raised nearly $527 million last year and spent roughly $506 million, new tax returns obtained by OpenSecrets reveal.

article thumbnail

New legislation is a great first step to lower drug prices

World of DTC Marketing

Most adults – across partisans – don’t believe high drug prices are needed for drug companies to invest in new research instead agreeing that “even if U.S. prices were lower, drug companies would still make enough money to invest in the research needed to develop new drugs.”. This theme should sound familiar. But it’s a lie.

article thumbnail

Trump’s lie on drug prices

World of DTC Marketing

According to the federal Centers for Medicaid and Medicare Services, our federal government spent $298 billion on prescription drugs at that time. March-in rights under Bayh-Dole have never been invoked, no doubt because the Pharmaceutical Research and Manufacturers of America, or PhRMA, has made clear that it would litigate.

article thumbnail

US Democrats’ blockbuster budget bill could spell big changes for drug prices

pharmaphorum

In addition to the climate provisions, however, the bill has a significant effect on prescription drug prices, and according to reports neither Manchin nor Sinema is objecting to these provisions, which are similar but not identical to the ones in the Build Back Better plan which previously passed in the House of Representatives.